Return to homepagePandemic Pact

Covid-19 vaccination in immunosuppressed individuals: An interdisciplinary collaboration to gain clinical and mechanistic insight into lasting immunity to SARS-CoV-2 infection

Grant number: 2021-04779

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $1,803,000

  • Funder

    TUBITAK

  • Principal Investigator

    Soo German

  • Research Location

    Sweden

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

6 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Immunogenicity of the Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in patients with cirrhosis.

Identification of soluble biomarkers that associate with distinct manifestations of long COVID.

Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities.

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.

Catch-up antibody responses and hybrid immunity in mRNA vaccinated patients at risk of severe COVID-19.